New Treatment Landscape in Multiple Sclerosis (MS)—Preventing Long-Term Disability Through High-Efficacy Treatments in Early MS

Supplements and Featured PublicationsMS Stakeholder Summit: New Treatment Landscape in Multiple Sclerosis (MS)—Preventing Long-Term Disability Through High-Efficacy Treatments in Early MS

This AJMC® Stakeholder Summit provides a multistakeholder perspective on opportunities to improve long-term disease outcomes in multiple sclerosis, as well as clinical and payer considerations with early use of high-efficacy therapies.

© 2023 MJH Life Sciences
AJMC®
All rights reserved.